Cargando…

ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Jeong, H M, Han, J, Lee, S H, Park, H-J, Lee, H J, Choi, J-S, Lee, Y M, Choi, Y-L, Shin, Y K, Kwon, M J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824018/ https://www.ncbi.nlm.nih.gov/pubmed/29155418 http://dx.doi.org/10.1038/oncsis.2017.89

Ejemplares similares

ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells
por: Jeong, H M, et al.
Publicado: (2017)

Correction: ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells
por: Jeong, H. M., et al.
Publicado: (2019)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2007)

ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer
por: Lee, Jihee, et al.
Publicado: (2022)

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
por: Klymenko, Yuliya, et al.
Publicado: (2017)

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers
por: Lee, Y-K, et al.
Publicado: (2009)

High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer
por: Deng, Guanming, et al.
Publicado: (2020)

Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer
por: Freytag, Morton, et al.
Publicado: (2020)

Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer: Erratum
Publicado: (2018)

Erratum to: The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
por: Crane, Lucia M. A., et al.
Publicado: (2012)

The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development
por: Bebee, Thomas W, et al.
Publicado: (2015)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
por: Horiguchi, K, et al.
Publicado: (2012)

NuMA Overexpression in Epithelial Ovarian Cancer
por: Brüning-Richardson, Anke, et al.
Publicado: (2012)

Dietary factors and epithelial ovarian cancer.
por: Shu, X. O., et al.
Publicado: (1989)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer
por: Feng, Y, et al.
Publicado: (2015)

Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression
por: Chen, Shuo, et al.
Publicado: (2021)

The anti-cancer effects of itraconazole in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2017)

Switch of the ovarian cancer cell to a calcifying phenotype in the calcification of ovarian cancer
por: Wen, Jirui, et al.
Publicado: (2018)

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer
por: Kwon, M J, et al.
Publicado: (2012)

Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
por: Morone, Simona, et al.
Publicado: (2012)

Overexpression of TAZ promotes cell proliferation, migration and epithelial-mesenchymal transition in ovarian cancer
por: Chen, Guangyuan, et al.
Publicado: (2016)

The Overexpression of Keratin 23 Promotes Migration of Ovarian Cancer via Epithelial-Mesenchymal Transition
por: Ren, Meng, et al.
Publicado: (2020)

Erratum to Genetic and molecular changes in ovarian cancer
por: Hollis, Robert L, et al.
Publicado: (2017)

Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer
por: Jolly, Mohit Kumar, et al.
Publicado: (2018)

Sialyl Tn as a prognostic marker in epithelial ovarian cancer.
por: Kobayashi, H., et al.
Publicado: (1992)

CDKN2A gene inactivation in epithelial sporadic ovarian cancer
por: Niederacher, D, et al.
Publicado: (1999)

Effects of capsaicin on laying performance, follicle development, and ovarian antioxidant capacity in aged laying ducks
por: Liu, J.G., et al.
Publicado: (2021)

Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
por: Roy, Debarshi, et al.
Publicado: (2014)

The Role of TWIST in Ovarian Epithelial Cancers
por: Kim, Kyungbin, et al.
Publicado: (2014)

Overexpression of piRNA Pathway Genes in Epithelial Ovarian Cancer
por: Lim, Shu Ly, et al.
Publicado: (2014)

Erratum: Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition
por: Zhang, Q, et al.
Publicado: (2017)

Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
por: Strauss, Robert, et al.
Publicado: (2011)

Erratum: Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype
por: Slattery, Martha L, et al.
Publicado: (2018)

Prognostic Characteristics of MACC1 Expression in Epithelial Ovarian Cancer
por: Jeong, Hoiseon, et al.
Publicado: (2018)

Results from the Survey of Antibiotic Resistance (SOAR) 2012–14 in Thailand, India, South Korea and Singapore
por: Torumkuney, D., et al.
Publicado: (2016)

Erratum: Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer
por: Seviour, E G, et al.
Publicado: (2016)

Erratum to: Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea
por: Park, Boyoung, et al.
Publicado: (2016)

Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.
por: Friedlander, M. L., et al.
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_nb8kl6nn8n74qhdjtthrcp8t5c